The Laboratory of Gastrointestinal Epithelial Biology in the Division of General and Gastrointestinal Surgery works to unravel the molecular mechanisms that underline the processes of growth and differentiation within intestinal epithelia, focusing on gut mucosal defense and how the host interacts with the intestinal microbiota.
The Liss Laboratory in the Division of General and Gastrointestinal Surgery at Massachusetts General Hospital is interested in understanding the molecular mechanisms that contribute to pancreatic cancer.
The Natural Orifice Translumenal Endoscopic Surgery (NOTES) Laboratory in the Division of General and Gastrointestinal Surgery evelops innovative minimally invasive techniques using the body's natural orifices to perform surgeries.
The focus of the basic and translational laboratory efforts is the molecular mechanisms underlying the initiation, progression, and maintenance of pancreatic disease and cancer, specifically the contribution of developmental genes.
The Massachusetts General Hospital Surgical Artificial Intelligence and Innovation Laboratory in the Department of Surgery focuses on the use of artificial intelligence to reimagine the way surgery is performed.
The main focus of the Thyroid Cancer Research Laboratory, led by Sareh Parangi, MD, is to study certain key genetic and epigenetic changes seen more frequently in those patients who do poorly, and find out how exactly these genetic changes lead to more aggressive cancer behavior in those patients.
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.
